Kirsti Kvaløy, Joel T. Minion, Chris Dibben, Isabel Fortier, Kim W. Carter, Gillian M. Raab, Ronald P. Stolk, Paul Burton, Mathieu Boniol, Susan E. Wallace, Catherine M. Phillips, Kristian Hveem, Chris Newby, Elinor Jones, Ivan J. Perry, Maria Bota, Richard W. Francis, Seán R. Millar, Oliver Butters, Julia Isaeva, Paolo Boffetta, Nuala A. Sheehan, Andrew Turner, Isabelle Budin-Ljøsne, Lisette Giepmans, Frank Popham, Andy Boyd, John Macleod, Bruce H R Woffenbuttel, Ipek Demir, Bartha Maria Knoppers, Carsten Oliver Schmidt, Eva Reischl, Barnaby Murtagh, Vincent Ferretti, Marja-Liisa Nuotio, Melanie Waldenberger, Philippe Laflamme, Yannick Marcon, Markus Perola, Edwin R. van den Heuvel, Jennifer R. Harris, Madeleine J Murtagh, Tero Hiekkalinna, N. Deklerk, Annette Peters, Amadou Gaye, Rebecca Wilson, Dany Doiron, Institute for Molecular Medicine Finland, Quantitative Genetics, Gaye, A., Marcon, Y., Isaeva, J., Laflamme, P., Turner, A., Jones, E.M., Minion, J., Boyd, A.W., Newby, C.J., Nuotio, M., Wilson, R., Butters, O., Murtagh, B., Demir, I., Doiron, D., Giepmans, L., Wallace, S.E., Budin-ljøsne, I., Oliver schmidt, C., Boffetta, P., Boniol, M., Bota, M., Carter, K.W., Deklerk, N., Dibben, C., Francis, R.W., Hiekkalinna, T., Hveem, K., Kvaløy, K., Millar, S., Perry, I.J., Peters, A., Phillips, C.M., Popham, F., Raab, G., Reischl, E., Sheehan, N., Waldenberger, M., Perola, M., Van den heuvel, E., Macleod, J., Knoppers, B.M., Stolk, R.P., Fortier, I., Harris, J.R., Woffenbuttel, B.H.R., Murtagh, M.J., Ferretti, V., Burton, P.R., Life Course Epidemiology (LCE), Lifestyle Medicine (LM), School of Social and Community Medicine [Bristol], University of Bristol [Bristol], McGill University Health Center [Montreal] (MUHC), Norwegian Institute of Public Health [Oslo] (NIPH), Department of Statistical Science, University College of London, University College of London [London] (UCL), Department of Infection, Immunity and Inflammation, Health Sciences, University of Leiceste, Institute for Molecular Medicine Finland (FIMM), Department of Chronic Disease Prevention, Unit of Public Health Genomics, National Institute for Health and Welfare [Helsinki], Department of Health Sciences [Leicester], University of Leicester, Department of Sociology [Leicester], Department of Epidemiology, University Medical Center Groningen, University of Groningen [Groningen], Greifswald University Hospital, International Prevention Research Institute (IPRI), The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai [New York] (MSSM), The University of Western Australia (UWA), School of Geosciences [Edinburgh], University of Edinburgh, Norwegian University of Science and Technology [Trondheim] (NTNU), Norwegian University of Science and Technology (NTNU), HRB Centre for Diet and Health Research, Department of Epidemiology and Public Health, University College Cork, Research Unit of Molecular Epidemiology, Research Center for Environmental Health, MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, University of Tartu, University Medical Center Groningen, Medical Statistic, Centre of Genomics and Policy [Montréal] (CGP), McGill University = Université McGill [Montréal, Canada], University Medical Center Groningen, LifeLines Cohort Study, Department of Endocrinology, University Medical Center Groningen, Ontario Institute for Cancer Research [Canada] (OICR), and Ontario Institute for Cancer Research
Gaye, Amadou Marcon, Yannick Isaeva, Julia LaFlamme, Philippe Turner, Andrew Jones, Elinor M Minion, Joel Boyd, Andrew W Newby, Christopher J Nuotio, Marja-Liisa Wilson, Rebecca Butters, Oliver Murtagh, Barnaby Demir, Ipek Doiron, Dany Giepmans, Lisette Wallace, Susan E Budin-Ljosne, Isabelle Oliver Schmidt, Carsten Boffetta, Paolo Boniol, Mathieu Bota, Maria Carter, Kim W deKlerk, Nick Dibben, Chris Francis, Richard W Hiekkalinna, Tero Hveem, Kristian Kvaloy, Kirsti Millar, Sean Perry, Ivan J Peters, Annette Phillips, Catherine M Popham, Frank Raab, Gillian Reischl, Eva Sheehan, Nuala Waldenberger, Melanie Perola, Markus van den Heuvel, Edwin Macleod, John Knoppers, Bartha M Stolk, Ronald P Fortier, Isabel Harris, Jennifer R Woffenbuttel, Bruce H R Murtagh, Madeleine J Ferretti, Vincent Burton, Paul R eng MC_UP_A540₁021/Medical Research Council/United Kingdom MR/K006525/1/Medical Research Council/United Kingdom Medical Research Council/United Kingdom Wellcome Trust/United Kingdom Research Support, Non-U.S. Gov't England 2014/09/30 06:00 Int J Epidemiol. 2014 Dec;43(6):1929-44. doi: 10.1093/ije/dyu188. Epub 2014 Sep 26.; International audience; BACKGROUND: Research in modern biomedicine and social science requires sample sizes so large that they can often only be achieved through a pooled co-analysis of data from several studies. But the pooling of information from individuals in a central database that may be queried by researchers raises important ethico-legal questions and can be controversial. In the UK this has been highlighted by recent debate and controversy relating to the UK's proposed 'care.data' initiative, and these issues reflect important societal and professional concerns about privacy, confidentiality and intellectual property. DataSHIELD provides a novel technological solution that can circumvent some of the most basic challenges in facilitating the access of researchers and other healthcare professionals to individual-level data. METHODS: Commands are sent from a central analysis computer (AC) to several data computers (DCs) storing the data to be co-analysed. The data sets are analysed simultaneously but in parallel. The separate parallelized analyses are linked by non-disclosive summary statistics and commands transmitted back and forth between the DCs and the AC. This paper describes the technical implementation of DataSHIELD using a modified R statistical environment linked to an Opal database deployed behind the computer firewall of each DC. Analysis is controlled through a standard R environment at the AC. RESULTS: Based on this Opal/R implementation, DataSHIELD is currently used by the Healthy Obese Project and the Environmental Core Project (BioSHaRE-EU) for the federated analysis of 10 data sets across eight European countries, and this illustrates the opportunities and challenges presented by the DataSHIELD approach. CONCLUSIONS: DataSHIELD facilitates important research in settings where: (i) a co-analysis of individual-level data from several studies is scientifically necessary but governance restrictions prohibit the release or sharing of some of the required data, and/or render data access unacceptably slow; (ii) a research group (e.g. in a developing nation) is particularly vulnerable to loss of intellectual property-the researchers want to fully share the information held in their data with national and international collaborators, but do not wish to hand over the physical data themselves; and (iii) a data set is to be included in an individual-level co-analysis but the physical size of the data precludes direct transfer to a new site for analysis.